ArticleInternational journal of oncology2025

Harnessing TP73‑targeted nintedanib: A novel strategy to halt triple‑negative breast cancer via p53‑PPARα/PI3K‑Akt pathway suppression.

Xiaomeng Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.